Product Program year 2025 Source: CMS Open Payments

Palforzia

Drug Allergy Treatment

Open in the dashboard

General payments

$283,360

358 payments

Research payments

$0

0 payments

Through program year 2025, $283,360 in general payments and $0 in research payments were reported against Palforzia (Allergy Treatment).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $277,428 110
2024 General $5,122 215
2023 General $810 33

Breakdown

Who paid General payments · program years 2023–2025
  1. Greer Laboratories, Inc. $283,360 358 payments
Top recipients General payments · program year 2025
  1. Anne Marie Irani Pediatrics · Richmond, VA $255,286 92% · 1 payment
  2. Panida Sriaroon Pediatric Allergy/Immunology · Saint Petersburg, FL $3,600 1% · 1 payment
  3. Susan Laubach Allergy & Immunology · San Diego, CA $2,345 <1% · 3 payments
  4. Malika Gupta Allergy & Immunology · Ann Arbor, MI $2,220 <1% · 2 payments
  5. Amanda Cox Pediatric Allergy/Immunology · New York, NY $2,200 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatrics $257,566 93% · 5 practitioners
  2. Pediatric Allergy/Immunology Pediatrics $12,377 4% · 12 practitioners
  3. Allergy & Immunology $3,802 1% · 45 practitioners
  4. Allergy & Immunology Internal Medicine $2,272 <1% · 2 practitioners
  5. Nurse Practitioner, Pediatrics Nurse Practitioner $375 <1% · 3 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Virginia $256,039 92% · 6 recipients
  2. Florida $5,871 2% · 4 recipients
  3. California $2,694 <1% · 8 recipients
  4. Massachusetts $2,402 <1% · 9 recipients
  5. New York $2,357 <1% · 7 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

358 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record